Metabolic disease
Conditions
Interventions
A:Intermittent fasting+obesity
B:Intermittent fasting+type 2 diabetes
C1:Intermittent fasting (4wks)+hypertension
C2:Intermittent fasting (10wks)+hypertension
D:Intermittent fasting+health
Sponsors
Northwest Minzu University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adult; 2. Obesity: BMI greater than 28 & No diagostic of cardiovascular disease; 3. Type 2 diabetes: Type 2 diabetes patients who meet the diagnostic criteria for diabetes issued by the World Health Organization (WHO) in 1999 & BMI greater than 18.5; 4. Hypertension: meet the diagnostic criteria of hypertension; 5. Can understand the procedures and methods of this study, willing to strictly abide by the clinical trial protocol to complete this trial, and voluntarily sign an informed consent.
Exclusion criteria
Exclusion criteria: 1. Antiboiotic use one month before the study; 2. Failed to provide informed consent form; 3. Other chronic disease (gastrointestinal disease, autoimmune disease, respiratory disease, heart disease, nervous system diseases, cancer) 4. Out of the defined MBI range; 5. Pregnant and lactating women; 6. Have a history of severe hypoglycemia episodes (such as sleepiness caused by hypoglycemia, unconsciousness, nonsense, and even coma); 7. Patients have no complete datas. 8. Previous participation in intermittent fasting intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gut microbiota;Blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood parameters;Body composition;Food intake;Basic characteristics; | — |
Countries
China
Contacts
Public ContactJunhong Su
Medical School of Kunming University of Science and Technology
Outcome results
None listed